nucleolin heterozygous knockout mice (Jackson Laboratory)
Structured Review

Nucleolin Heterozygous Knockout Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+knockout+%26+mutation+database/heterozygous+mice/pmc13253107-22-0-9
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "A role for nucleolin in functional improvement in stroke"
Article Title: A role for nucleolin in functional improvement in stroke
Journal: iScience
doi: 10.1016/j.isci.2026.116134
Figure Legend Snippet: Ischemic cortical stroke increases nucleolin expression in excitatory neurons (A) Representative coronal section stained with DAPI with stroke (red dashed line) and area of interest (yellow box). (B) Representative in situ hybridization images of DAPI (nuclear counterstain), Slc17a7 (excitatory cortical neurons), Gad1 (inhibitory neurons), and nucleolin at time points across acute to chronic stroke. The dashed box indicates the region shown at higher resolution and magnification in accompanying panels. Scale bars, 20 μm, n = 5 animals per time point. (C) Quantification of nucleolin mRNA expression in excitatory cortical neurons post-stroke. Stroke induces both early and chronic expression of nucleolin in Slc17a7 + cells. 1-way ANOVA with post-hoc Tukey correction. Data are represented as mean ± SEM with data points representing individual animals. ∗ p = 0.039, ∗∗∗ p = 0.003 (3D post stroke), p = 0.004 (7D post stroke). (D) Quantification of nucleolin mRNA expression in inhibitory cortical neurons post-stroke. No significant change in nucleolin expression was detected in Gad1 + cells. Data are represented as mean ± SEM with data points representing individual animals. (E) Representative images of nucleolin protein expression in sham stroke and 7 days post-stroke mice. Scale bars, 10 μm, n = 5 animals per group. (F) Quantification of nucleolin protein expression post-stroke. Stroke significantly increases nucleolin expression 7 days post-stroke ( p = 0.0005 via t test). Data are represented as mean ± SEM with data points representing individual animals.
Techniques Used: Expressing, Staining, In Situ Hybridization
Figure Legend Snippet: Heterozygous deletion of the nucleolin GAR domain is detrimental to post-stroke axonal sprouting (A) Representative in situ hybridization images show reduced nucleolin expression in GAR +/- mice. The dashed box indicates the region shown at higher resolution and magnification in accompanying panels. Scale bars, 20 μm, n = 5 animals per group. (B) Quantification of nucleolin mRNA in GAR wild type (GAR +/+ ) and heterozygous deletion (GAR +/- ) mice. GAR +/- mice show a significant reduction in nucleolin mRNA puncta in excitatory cortical neurons ( p = 0.004 via t test). Data are represented as mean ± SEM with data points representing individual animals. (C) Schematic shows the general surgery procedure. Generated via BioRender. (D) Quantitative cortical mapping of peri-infarct axonal sprouting in GAR heterozygous deletion mice compared to wild type littermates. Injection site noted via white circle. Stroke site indicated via black symbol. Heterozygous deletion of the nucleolin GAR domain significantly decreases peri-infarct axonal sprouting when compared to wild-type littermate controls ( p = 0.006 via Hotelling’s T2 test). (E) Axonal puncta distribution within concentric rings centered at the injection origin (0,0). Heterozygous deletion of the nucleolin GAR domain significantly reduces axon detection at distances greater than 3 mm from the injection site (∗ p = 0.0329, ∗∗ p = 0.00286, and ∗∗∗∗ p < 0.0001, general linear mixed model with post-hoc Tukey’s correction). Data are represented as mean ± SEM. (F) Representative cortical flat-map images of wild-type and heterozygous GAR deletion mice 1 month following cortical stroke. White circle indicates the tracer injection site, and the red dashed circle indicates the outer bounds of infarct. (G) Heterozygous deletion of the nucleolin GAR domain results in an approximately 2-fold increase in infarct size one month post stroke ( p = 0.0078 via t test). n = 5 animals per group for all measurements. Data are represented as mean ± SEM with data points representing individual animals.
Techniques Used: In Situ Hybridization, Expressing, Generated, Injection
Figure Legend Snippet: GAR-induced somatic sequestration of nucleolin enhances post-stroke axonal sprouting (A) Quantitative cortical mapping of post-stroke axonal sprouting in flattened mouse cortex ipsilateral to the stroke. Exogenous GAR-induced somatic sequestration of nucleolin, injection site noted by the white circle, results in a significant increase in axonal sprouting to the adjacent somatosensory cortex compared to Dendra2 control virus ( p = 0.02727 via Hotelling’s T2 test). Stroke indicated via a black symbol. (B) Axonal puncta distribution within concentric rings centered at the injection site (0,0). Somatic sequestration of nucleolin significantly increases axon detection locally and distant from the injection site (∗∗ p = 0.00234, ∗∗∗ p = 0.000486, and ∗∗∗∗ p < 0.0001, general linear mixed model with post-hoc Tukey’s correction). Data are represented as mean ± SEM. (C) Representative flatmap images of mice injected with control and GARWT viruses. The white circle indicates the virus injection site, and the red dashed circle indicates the border of the infarct. Yellow square indicates zoomed in image, showing colocalization of Flag and NeuN in virally transduced cells. Scale bars, 20 μm, n = 5–7 animals per group. (D) Quantification of infarct size. Somatic sequestration of nucleolin does not impact infarct size ( p = 0.6989 via t test). n = 7 animals per group for all measurements. Data are represented as mean ± SEM with data points representing individual animals.
Techniques Used: Injection, Control, Virus
Figure Legend Snippet: Nucleolin perturbation enhances post-stroke functional recovery (A) Diagram of grid-walking and pasta matrix tasks, and experimental timeline for task training and assessment post-stroke. (B) Somatic sequestration of nucleolin accelerates recovery in the pasta matrix fine motor control and grid-walking gross motor control tasks. Mice were evaluated for fine motor dexterity as defined by the percentage of baseline pieces of pasta broken. One-week post-stroke, both GARWT + stroke and Control + stroke mice showed a significant deficit in the number of pieces of pasta broken compared to Control alone (∗Control vs. Stroke + Control p = 0.0082, # Control vs. Stroke + GARWT p = 0.0003 via 2-way ANOVA). Three weeks post-stroke, Control + stroke mice continued to show a deficit, whereas GARWT + stroke mice had recovered to a degree with no significant difference from both control groups (∗ Control vs. Control + stroke p = 0.0021, Control vs. GARWT + stroke p = 0.4568, $ Control + stroke vs. GARWT + stroke p = 0.0280 via 2-way ANOVA). By five weeks post-stroke, both groups showed no significant difference from the control groups. N = 8–10 per group. Mice were evaluated for gross motor control as defined by the fold change of baseline percentage right foot faults. One-week post-stroke, Control + stroke and GARWT + stroke mice showed a significant increase in the relative number of foot faults involving the affected limb (∗Control vs. Control + stroke p = 0.0180, # Control vs. GARWT + stroke p = 0.0202 via 2-way ANOVA). At the endpoint of the experiment, 8 weeks post-stroke, Control + stroke mice showed a continued fold change increase in percent foot faults, whereas GARWT + stroke mice were not significantly different from Control alone (∗Control vs. Control + stroke p = 0.0323, Control vs. GARWT + stroke p = 0.3322). n = 12–15 per group. Data are represented as mean ± SEM. (C) Representative DAPI-stained cortical sections of stroke mice treated with control or GARWT virus. Yellow box outlines the peri-infarct region imaged for tissue-level outcomes, red dashed circle indicates infarct bounds. Scale bars, 20 μm. (D) Somatic sequestration of nucleolin has no effect on infarct size or tissue loss. n = 8 per group. p < 0.0001, control vs. control + stroke and control vs. GARWT + stroke via 2-way ANOVA with Tukey’s post-hoc correction. Data are represented as mean ± SEM with data points representing individual animals. (E) Somatic sequestration of nucleolin does not have an effect on Iba1 intensity following cortical stroke. n = 8 per group. Data are represented as mean ± SEM with data points representing individual animals.
Techniques Used: Functional Assay, Control, Staining, Virus
Related Articles
Mouse Assay:Article Title: Article Snippet: .. Auto-D2-KO mice were bred at the VAPORHCS Veterinary Medical Unit by crossing Drd2 loxP/loxP mice ( 53 ), obtained from Jonathan Javitch (Columbia University, USA), with Article Title: A role for nucleolin in functional improvement in stroke Article Snippet: .. Knock-Out:Article Title: A role for nucleolin in functional improvement in stroke Article Snippet: .. Article Title: A role for nucleolin in functional improvement in stroke Article Snippet: .. Transgenic Assay:Article Title: Disruption of the brain-spleen axis impairs monocyte-microglia communication and accelerates disease progression in a mouse model of amyloidosis. Article Snippet: .. For all experiments, other:Article Title: Age-Dependent Remodeling of the Sciatic Nerve Proteome in 5xFAD Mice Can Be Attenuated by Exercise or Donepezil Treatment to Maintain Neuromuscular Function. Article Snippet: Article Title: Developmental CA2 perineuronal net reduction restores social memory in Shank3 mutant mice. Article Snippet: Male and RNA Sequencing:Article Title: NPAS3-regulated astrocyte mitochondrial bioenergetics is required for cognition. Article Snippet: .. Heterozygous Npas3+/− ( |

